← Back to RYTM

Rhythm Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 04/08/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 04/08/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$71$60$51$49$33$33$29$26
−$49−$56−$53−$47−$49−$44−$32−$141
−$0.73−$0.83−$0.82−$0.75−$0.81−$0.73−$0.55−$2.35
6968666463616160

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.